In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)

The spread of SARS-CoV-2 has affected human health globally. Hence, it is necessary to rapidly find the drug-candidates that can be used to treat the infection. Since the main protease (M(pro)) is the key protein in the virus's life cycle, M(pro) is served as one of the critical targets of anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghaee, Elham, Ghodrati, Marzieh, Ghasemi, Jahan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801185/
https://www.ncbi.nlm.nih.gov/pubmed/33457495
http://dx.doi.org/10.1016/j.imu.2021.100516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801185/
https://www.ncbi.nlm.nih.gov/pubmed/33457495
http://dx.doi.org/10.1016/j.imu.2021.100516

Ejemplares similares